Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Dabigatran etexilate by Hong Kong WD Pharmaceutical for Pulmonary Embolism: Likelihood of Approval
Dabigatran etexilate is under clinical development by Hong Kong WD Pharmaceutical and currently in Phase I for Pulmonary Embolism. According...
Dabigatran etexilate by Hong Kong WD Pharmaceutical for Deep Vein Thrombosis (DVT): Likelihood of Approval
Dabigatran etexilate is under clinical development by Hong Kong WD Pharmaceutical and currently in Phase I for Deep Vein Thrombosis...
Dabigatran etexilate by Hong Kong WD Pharmaceutical for Stroke: Likelihood of Approval
Dabigatran etexilate is under clinical development by Hong Kong WD Pharmaceutical and currently in Phase I for Stroke. According to...